McPherson's Resultados de beneficios anteriores

Pasado controles de criterios 0/6

McPherson'shan disminuido a un ritmo medio anual de -56.6%, mientras que en la industria Personal Products los ingresos han sido de growing a 8.9% anuales. Los ingresos han sido growing a una tasa media anual de 0.08%.

Información clave

-60.8%

Tasa de crecimiento de los beneficios

-61.4%

Tasa de crecimiento del BPA

Crecimiento de la industria Personal Products	-25.2%
Tasa de crecimiento de los ingresos	-0.4%
Rentabilidad financiera	-3.3%
Margen neto	-1.8%
Última actualización de beneficios	31 Dec 2023

Actualizaciones de resultados anteriores recientes

Recent updates

McPherson's Limited's (ASX:MCP) Shares Climb 35% But Its Business Is Yet to Catch Up

Dec 18

These 4 Measures Indicate That McPherson's (ASX:MCP) Is Using Debt Reasonably Well

May 17

Did You Participate In Any Of McPherson's' (ASX:MCP) Fantastic 149% Return ?

Feb 12

Are McPherson's's (ASX:MCP) Statutory Earnings A Good Guide To Its Underlying Profitability?

Jan 25

Declining Stock and Decent Financials: Is The Market Wrong About McPherson's Limited (ASX:MCP)?

Jan 07

A Look At The Intrinsic Value Of McPherson's Limited (ASX:MCP)

Dec 20

Analysts Just Shaved Their McPherson's Limited (ASX:MCP) Forecasts Dramatically

Dec 03

Tread With Caution Around McPherson's Limited's (ASX:MCP) 5.0% Dividend Yield

Nov 22

Have Insiders Been Buying McPherson's Limited (ASX:MCP) Shares This Year?

Sep 10

Here's What McPherson's Limited's (ASX:MCP) Shareholder Ownership Structure Looks Like

Aug 19

McPherson's Limited (ASX:MCP) P/E Isn't Throwing Up Surprises

Jul 30

Is McPherson's Limited (ASX:MCP) Expensive For A Reason? A Look At Its Intrinsic Value

Jul 15

Should McPherson's Limited (ASX:MCP) Be Part Of Your Dividend Portfolio?

Jun 29

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero McPherson's. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

ASX:MCP Ingresos, gastos y beneficios (AUD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	202	-4	75
30 Sep 23	206	-4	74
30 Jun 23	210	-5	74
31 Mar 23	214	-1	74
31 Dec 22	217	3	73
30 Sep 22	216	1	72
30 Jun 22	214	0	71
31 Mar 22	211	-4	70
31 Dec 21	208	-9	70
30 Sep 21	204	-7	69
30 Jun 21	201	-5	68
31 Mar 21	210	-2	66
31 Dec 20	218	1	64
30 Sep 20	221	4	64
30 Jun 20	223	6	64
31 Mar 20	216	10	64
31 Dec 19	210	14	65
30 Sep 19	210	14	66
30 Jun 19	210	14	66
31 Mar 19	211	12	34
31 Dec 18	211	11	66
30 Sep 18	211	11	66
30 Jun 18	211	11	66
31 Mar 18	207	10	66
31 Dec 17	203	8	66
30 Sep 17	208	4	65
30 Jun 17	212	0	65
31 Mar 17	235	-1	72
31 Dec 16	259	-1	79
30 Sep 16	286	5	86
30 Jun 16	313	11	92
31 Mar 16	323	10	94
31 Dec 15	333	10	95
30 Sep 15	341	9	98
30 Jun 15	350	9	101
31 Mar 15	353	11	102
31 Dec 14	357	12	104
30 Sep 14	355	-27	103
30 Jun 14	353	-67	102
31 Mar 14	340	-91	102
31 Dec 13	327	-114	101
30 Sep 13	313	-74	97
30 Jun 13	299	-33	92

Ingresos de calidad: MCP actualmente no es rentable.

Margen de beneficios creciente: MCP actualmente no es rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: MCP no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 56.6% al año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de MCP en el último año con su media de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: MCP no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el del sector Personal Products (10.2%).

Rentabilidad financiera

Alto ROE: MCP tiene un Rendimiento de los fondos propios negativo (-4.62%), ya que actualmente no es rentable.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

McPherson's Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Información clave

Actualizaciones de resultados anteriores recientes

First half 2024 earnings released: EPS: AU$0.011 (vs AU$0.001 in 1H 2023)

Full year 2023 earnings: EPS and revenues miss analyst expectations

McPherson's Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

First half 2023 earnings: EPS misses analyst expectations

McPherson's Limited to Report First Half, 2023 Results on Feb 28, 2023

Full year 2022 earnings: EPS misses analyst expectations

Recent updates

First half 2024 earnings released: EPS: AU$0.011 (vs AU$0.001 in 1H 2023)

Price target increased by 25% to AU$0.67

Upcoming dividend of AU$0.02 per share

New minor risk - Share price stability

McPherson's Limited Announces Executive Changes

McPherson's Limited's (ASX:MCP) Shares Climb 35% But Its Business Is Yet to Catch Up

Here's Why McPherson's (ASX:MCP) Can Manage Its Debt Responsibly

McPherson's Limited, Annual General Meeting, Nov 28, 2023

Price target decreased by 14% to AU$0.54

McPherson's (ASX:MCP) Will Pay A Smaller Dividend Than Last Year

Upcoming dividend of AU$0.01 per share at 4.0% yield

McPherson's Limited Announces Ordinary Fully Paid Dividend for the Six Months Ended June 30, 2023, Payable on September 22, 2023

Full year 2023 earnings: EPS and revenues miss analyst expectations

McPherson's Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Less than half of directors are independent

A Look At The Fair Value Of McPherson's Limited (ASX:MCP)

McPherson’s Limited Appoints Brett Charlton as Chief Executive Officer, Effective 1 August 2023

Now 22% undervalued after recent price drop

Mcpherson's Limited Announces Resignation of Grant Peck as Chief Executive Officer, Effective 31 May 2023

Consensus EPS estimates fall by 29%, revenue upgraded

These 4 Measures Indicate That McPherson's (ASX:MCP) Is Using Debt Reasonably Well

Price target decreased by 7.9% to AU$0.78

Now 24% undervalued after recent price drop

First half 2023 earnings: EPS misses analyst expectations

Price target decreased by 11% to AU$0.84

Now 23% undervalued after recent price drop

McPherson's Limited Appoints Linda Gough as Company Secretary

Price target decreased to AU$0.84

McPherson's Limited to Report First Half, 2023 Results on Feb 28, 2023

Consensus forecasts updated

McPherson's Limited Announces Resignation of Geoffrey Pearce as Director, Effective November 22, 2022

McPherson's Limited, Annual General Meeting, Nov 22, 2022

Upcoming dividend of AU$0.02 per share

Full year 2022 earnings: EPS misses analyst expectations

McPherson's Limited Declares Fully Franked Final Dividend for the Year 2022, Payable on 23 September 2022

McPherson's Limited to Report Fiscal Year 2022 Results on Aug 25, 2022

First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Mcpherson's Limited Announces Board Changes

McPherson's Limited Announces Changes to Its Board

McPherson's Limited to Report First Half, 2022 Results on Feb 23, 2022

Price target decreased to AU$1.19

Arrotex Pharmaceuticals Pty Limited cancelled the acquisition of McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others.

Price target increased to AU$1.53

Arrotex Pharmaceuticals Pty Limited made a Non-binding Indicative Offer to acquire McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others for approximately AUD 210 million.

McPherson's Limited Provides Earnings Guidance for the Full Year 2021

McPherson's Limited Not Providing Earnings Guidance Due to COVID-19

McPherson's Limited Appoints Ari Mervis as Independent, Non-Executive Director to the Board

Did You Participate In Any Of McPherson's' (ASX:MCP) Fantastic 149% Return ?

McPherson's Limited to Report First Half, 2021 Results on Feb 17, 2021

Are McPherson's's (ASX:MCP) Statutory Earnings A Good Guide To Its Underlying Profitability?

Declining Stock and Decent Financials: Is The Market Wrong About McPherson's Limited (ASX:MCP)?

A Look At The Intrinsic Value Of McPherson's Limited (ASX:MCP)

Investor sentiment improved over the past week

McPherson's CEO Change

Market pulls back on stock over the past week

New 90-day low: AU$1.15

Analysts Just Shaved Their McPherson's Limited (ASX:MCP) Forecasts Dramatically

Price target lowered to AU$2.36

Analysts lower EPS estimates to AU$0.083

Market pulls back on stock over the past week

Tread With Caution Around McPherson's Limited's (ASX:MCP) 5.0% Dividend Yield

New 90-day low: AU$2.18

Analysts update estimates

McPherson's Limited (ASX:MCP) entered into an agreement to acquire Global Therapeutics Pty Ltd from Blackmores Limited (ASX:BKL) for an enterprise value of AUD 27 million.

Analysts update estimates

New 90-day low: AU$2.64

Have Insiders Been Buying McPherson's Limited (ASX:MCP) Shares This Year?

Independent Non-Executive Director recently bought AU$133k worth of stock

New 90-day high - AU$3.18

Desglose de ingresos y gastos
Beta